CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Gemma Navarro

OPENALEX: A5014576744↗ORCID: 0000-0003-4654-0873↗

Affiliations

Organizations

Biomedical Research Networking Center on Neurodegenerative Diseasesauthorship · ES Centro de Investigación Biomédica en Redauthorship · ES Instituto de Salud Carlos IIIauthorship · ES Universitat de Barcelonaauthorship · ES

Public evidence

4 connected articles

A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.2023 · Europe PMC Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes.2018 · Europe PMC Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors.2017 · Europe PMC Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors2015 · PubMed Central Open Access

Registered research

Connected studies

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adultsnct05743985

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Gemma Navarro - Medical Cannabis Research Engine